POU5F1 and neoplasm: The significant difference in nuclear OCT4 and nucleocytoplasmic NANOG expressions between ccRCC, compared with the chRCC and pRCC tumor samples, indicates that OCT4 and NANOG may act as a diagnostic markers to distinguish ccRCC from chRCC and pRCC subtypes.